CKGSB Investor Sentiment Survey Found More Chinese Investors Retreat to Safe Assets
Respondents this quarter expressed notably high concerns about international relations and the impact on their investment decisions. About 63.6% of respondents found Sino-US relations to have a major impact on investment, about 56.8% considered China's relations with Western countries important, and about 58.8% believed that a broken China-US trade relationship will lead to heavy short-term pressure for China.
With their eye on the resilience of the private economy, technological breakthroughs, and government support to the domestic economy, however, investors are found optimistic that China would not suffer too badly from the long-term impact of the trade war. About 45.8% of respondents saw the future in a positive light and as many as 20% thought China would ride out the storm without significant impact.
As real estate, the main source of wealth for the vast majority of Chinese families, has fallen in value ever since August 2020, and with the external geopolitical and trade challenges, China will have to recalibrate its growth with domestic demand. About 58.2% of respondents believed that boosting domestic demand would have a big impact on future investment.
It also found investors' expectations for China's A-shares to be consistent with the trajectory of the stock market itself. After November's net increase in willingness to invest of 11.3% over July 2024, this April saw net future willingness to invest reaching 12.7%.
Investors were confident that China is in a leading position in important scientific and technological fields and that this would result in significant growth. About 54.4% of respondents responded China was a world leader in AI, up 14.7 percentage points from November 2024.
The survey showed that the status of the private economy is crucial to their future investment decisions, with 44.5% of respondents affirming this view in April 2025.
The Cheung Kong Graduate School of Business Investor Sentiment Survey (CKISS) is a survey on China's investor sentiment and expectations in the capital market, produced by Professor Liu Jing, CKGSB Professor of Accounting and Finance.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
4 hours ago
- Korea Herald
Maldives and Henley & Partners Sign Landmark Partnership Agreement to Launch Pioneering Residence by Investment Program
MALÉ, Maldives, July 1, 2025 /PRNewswire/ -- The Government of the Maldives has signed a landmark partnership agreement with Henley & Partners, the world's leading international investment migration advisory firm, to develop and implement the nation's first-ever residence by investment program. This groundbreaking collaboration supports President Dr. Mohamed Muizzu's Vision 2040, which aims to transform the Maldives into a fully developed, resilient, and diversified economy. Mr. Mohamed Saeed, Minister of Economic Development and Trade, speaking at the sidelines of the signing ceremony which was held at the Maldives–Singapore Business Forum 2025 on Sentosa Island in Singapore, said: "The Maldives has long been a world-class destination for travelers. With this program, we aim to extend that legacy to discerning global investors who see value in our people, our potential, and our future. This partnership with Henley & Partners reflects our confidence in aligning with reputable global players to achieve economic diversification and national resilience under President Dr. Mohamed Muizzu's visionary leadership and Vision 2040 targets." Recognized globally as one of the world's most iconic luxury destinations, the Maldives intends to offer discerning global investors a unique opportunity to establish long-term residence in what is often described as a tropical paradise, comprising of 1,190 Coral Islands each surrounded by crystal-blue lagoons and grouped in a double chain of 27 atolls and spread over roughly 90,000 square kilometers. Philippe Amarante, Managing Partner and Head of Government Advisory EMEA at Henley & Partners, told guests attending the ceremony that the new investment migration program will capitalize on the country's world-class real estate offerings. "The residence by investment program will provide state-of-the-art properties with the utmost privacy and exclusivity. As a safe, stable, and peaceful island nation, the Maldives presents the ultimate hedge against geopolitical conflict or global pandemics, offering an unparalleled lifestyle and security to high-net-worth individual investors and their families."
Korea Herald
4 hours ago
- Korea Herald
FHC Shanghai 2025 Opens Global Gateway to China's Food Market
SHANGHAI, July 1, 2025 /PRNewswire/ -- The 28th edition of FHC Shanghai Global Food Trade Show will return to the Shanghai New International Expo Centre (SNIEC) from November 12–14, 2025. As Asia's premier food and beverage trade platform, FHC Shanghai will be held by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd. which connects 3,000+ exhibitors from 100+ countries with 180,000+ professional buyers, solidifying its role as the critical gateway for global brands entering China's $1.5 trillion food market. Spanning 200,000 SQM the exhibition will showcase 15 product sectors including Meat, Sea Food, Leisure Food & Beverage, Dairy, Sweets & Chocolate, Catering Supply Chain & Raw Material, Condiments & Oil, Coffee & Tea, Bakery & Light Meal, Food Processing & Packaging, Prefabricated Dishes & Central Kitchen, Canned Food & Raw Materials, Machinery and Equipment, Hot Pot Ingredients and Supplies, Homology of Medicine and Food, Baby Food. The 2024 event drew record participation with pavilions from 50+ countries & regions, and FHC 2025 announces its first wave of international pavilions: representing Italy, Japan, Spain, Türkiye, Germany, Austria, Australia, Britain, Armenia, Thailand, Russia, and additional nations. There was 171,828 visitors, underscoring its industry influence. Strategic Highlights for 2025: Buyer Engagement: Targeted outreach to importers (20.61%), distributors (22.94%), e-commerce platforms, and hospitality chains. Global Participation: Enhanced international pavilions and Hosted Buyer Program for key markets (USA, Italy, UK, ASEAN). Knowledge Hub: Concurrent forums on food e-commerce, sustainable catering, and retail innovation. Competitions: Features coffee series events endorsed by World Coffee Events, culinary competitions certified by the World Association of Chefs Societies, and other specialized event categories. We look forward to seeing you in November!
Korea Herald
4 hours ago
- Korea Herald
Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics
SEOUL, South Korea, July 1, 2025 /PRNewswire/ -- Seegene Inc., a global leader in molecular diagnostics (MDx) solutions, announced today the launch of STAgora™, a next-generation platform for infectious disease analytics. Designed as a real-time infectious disease intelligence system, the platform combines diagnostic data with advanced statistical modeling and aims to redefine how the world detects, tracks, and responds to outbreaks. STAgora™ provides real-time global visualization of infectious disease trends at the municipal, national, and continental levels, based on actual diagnostic test results. The platform delivers healthcare professionals immediate, structured diagnostic reports and statistical analyses in clear, actionable formats. These are supported by customizable dashboards and real-time alert functions. In addition to tracking individual cases, STAgora™ enables users to monitor outbreaks across selected regions, both local and international. This capability provides real-time visibility into disease spread, enhancing situational awareness and supporting timely, data-driven public health responses. By equipping national and global health authorities with real-time epidemiological insight, the platform is expected to strengthen decision-making and support the development of effective response strategies to mitigate large-scale infectious disease outbreaks. With more than 40 built-in statistical tools, STAgora™ enables early detection of abnormal pathogen patterns and supports predictive modeling for seasonal trends and emerging outbreaks. These tools include modules for tracking individual infections, analyzing symptom-based co-infections and calculating real-time infection rate trends. Together, they help transform static data into forward-looking intelligence that guides proactive interventions. Unlike traditional outbreak monitoring systems that rely on retrospective data, STAgora™ performs real-time analysis of PCR-derived diagnostics. This allows for immediate visibility into pathogen spread and, through AI-based algorithms, the forecasting of potential future outbreaks. "The key differentiator of STAgora™ is its unique architecture, which aggregates real-time diagnostic data from around the world into a unified analysis platform," said Young-Seag Baeg, head of strategic planning at Seegene. When paired with Seegene's proprietary syndromic quantitative PCR technology, STAgora™ offers expanded visibility into both single-pathogen infections and simultaneous multi-pathogen co-infections. This comprehensive diagnostic insight empowers clinicians to make faster, more informed decisions at the point of care. "During the COVID-19 pandemic, we saw firsthand how crucial accurate and timely interpretation of diagnostic data was in shaping public health policies and clinical outcomes," said Daniel Shin, executive vice president and chief global sales and marketing officer at Seegene. "Now, as we confront increasingly complex threats such as antimicrobial resistance, viral mutations and co-infections, the ability to deliver actionable insights from diagnostic data is becoming a cornerstone of clinical innovation and a vital pillar of global health security." Seegene will officially debut STAgora™ at the 2025 Association for Diagnostics & Laboratory Medicine (ADLM) annual meeting, taking place July 27 to 31 in Chicago, USA. The event will highlight key capabilities of the platform, including its integration with CURECA™, Seegene's fully automated, unmanned PCR system. ADLM 2025 will also serve as a launchpad for Seegene to explore global collaboration and partnerships with healthcare leaders and clients. With the launch of STAgora™, Seegene aims to lay the foundation for a smarter, faster and more connected global health defense system. By combining real-time molecular diagnostics, AI-driven analytics and global data integration, STAgora™ represents a strategic step toward building an intelligent public health infrastructure capable of responding proactively to emerging threats. The company envisions the platform as a core pillar of the global infectious disease response framework, marking a new step toward enhanced diagnostic insight and preparedness. About Seegene Seegene has more than 20 years of dedicated experience in R&D, manufacturing, and business related to syndromic real-time PCR technologies. This expertise was particularly highlighted during the COVID-19 pandemic when Seegene provided over 340 million COVID-19 tests to more than 100 countries worldwide. The core feature of Seegene's syndromic real-time PCR technology is the ability to simultaneously test for 14 pathogens that cause similar signs and symptoms in a single tube with quantitative information. CURECA™(Continuous, Unlimited, Random-access, Expandable, and Customizable Automation) is a fully automated and modular PCR system that eliminates manual processes and enables continuous, real-time testing. It is a unified platform designed to operate continuously, 24 hours a day, with no human intervention. The very core feature is CPS which is the first part of CURECA™, the world's first automated pre-treatment system capable of handling a full spectrum of specimen types, including blood, stool, sputum, and urine. Designed to support both centralized and decentralized labs, CURECA offers scalable automation and flexible adoption—making it especially valuable in settings with limited space or personnel.
